Altimmune to report third quarter 2023 financial results and provide business update on november 7, 2023

Gaithersburg, md., oct. 31, 2023 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2023 financial results on tuesday, november 7, 2023 and will provide a business update.
ALT Ratings Summary
ALT Quant Ranking